ArticleFrontiers in cellular and infection microbiology2023

HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors.

Jiaming Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.